Clicky

Pacific Biosciences of California, Inc.(PACB)

Description: Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes. Its SMRT technology enables to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. It primarily focuses on the deoxyribonucleic acid sequencing market. The company's product includes the PacBio RS high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company's customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.


Keywords: Biotechnology Life Sciences Biology Molecular Biology Acid Genomics Bioinformatics DNA Sequencing Genome Fluidics Smrt

Home Page: www.pacb.com

PACB Technical Analysis

1305 O’Brien Drive
Menlo Park, CA 94025
United States
Phone: 650 521 8000


Officers

Name Title
Mr. Christian O. Henry M.B.A. Pres, CEO & Director
Ms. Susan G. Kim Chief Financial Officer
Mr. Mark Van Oene Chief Operating Officer
Dr. Denis Zaccarin Ph.D. Sr. VP of Product Devel.
Dr. Stephen Turner Co-Founder & CTO
Ms. Michele Farmer CPA VP & Chief Accounting Officer
Dr. Jonas Korlach Ph.D. Chief Scientific Officer
Trevin Rard Head of Investor Relations
Dr. Brett Atkins J.D., Ph.D. Gen. Counsel & Corp. Sec.
Ms. Natalie Welch Chief People Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.4029
Price-to-Sales TTM: 14.9562
IPO Date: 2010-10-27
Fiscal Year End: December
Full Time Employees: 728
Back to stocks